AGX.NYSEArgan INC

Form 4: Argan Inc. CFO Richard Deily Reports Stock Option Exercises and Vesting of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Richard Deily, CFO and SVP of Argan Inc., reports exercising stock options and the vesting of restricted stock units, resulting in changes to his beneficial ownership of company stock.

Summary

  • On April 16, 2024, Richard Deily, the CFO and SVP of Argan Inc., exercised stock options to purchase a total of 30,000 shares of Argan Inc.'s common stock at prices of $33.85, $37.60, and $33.81 per share.
  • Also on April 16, 2024, 1,166 shares of common stock became issuable to Deily due to the vesting of time-based restricted stock units (TRSUs) awarded on April 16, 2021.
  • On April 18, 2024, an additional 1,167 shares became issuable to Deily due to the vesting of TRSUs awarded on April 18, 2022.
  • These transactions changed Deily's direct ownership of Argan Inc. common stock to 14,441 shares.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to executive compensation, and does not contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

Executive stock option exercises and vesting of restricted stock units are common forms of compensation in publicly traded companies, aligning management's interests with those of shareholders.

Comparison to Industry Standards

  • Stock option grants and vesting schedules are typical components of executive compensation packages in the engineering and construction industry, similar to companies like Fluor Corporation (FLR) and Jacobs Engineering Group (J).
  • The vesting schedules for restricted stock units, often spanning three years, are consistent with industry norms for incentivizing long-term performance and retention.
  • Executive stock ownership guidelines, which encourage executives to hold a certain amount of company stock, are also common practice to align interests with shareholders.

Stakeholder Impact

  • The transactions reported in the Form 4 filing may have a minor dilutive effect on existing shareholders due to the issuance of new shares upon option exercise and vesting of restricted stock units.
  • The vesting of restricted stock units and exercise of stock options incentivize the executive to continue to perform well for the company.

Key Dates

DateDescription
04/13/2016Date of stock option award with an exercise price of $33.85 per share.
04/13/2017Stock options awarded on this date expire on 04/13/2026.
04/13/2018Date of stock option award with an exercise price of $37.60 per share.
04/13/2019Stock options awarded on this date expire on 04/13/2028.
04/16/2021Date of stock option and TRSU awards.
04/16/2022Date of TRSU award.
04/16/2024Exercise of stock options and vesting of TRSUs.
04/18/2024Vesting of TRSUs.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.